We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search

Content type



9 results found


Baker Botts LLP | USA | 24 Jun 2011

DOJ revises Policy Guide to reflect greater flexibility in fashioning merger remedies

On June 17, 2011, the Antitrust Division of the Department of Justice (“DOJ”) updated its Policy Guide to Merger Remedies, signaling a shift toward a more flexible, case-by-case approach to merger remedies.


Baker Botts LLP | USA | 26 May 2011

SEC approves final Dodd-Frank whistleblower rules

On May 25, 2011, the SEC voted to approve the Final Rules implementing the whistleblower provisions of Dodd-Frank.


Baker Botts LLP | USA | 14 Dec 2010

In-house counsel indicted for alleged false statements and obstruction

Lauren Stevens, a former Vice-President and Associate General Counsel for GlaxoSmithKline was indicted on November 8 by the Justice Department for allegedly obstructing a United States Food and Drug Administration (FDA) proceeding by concealing requested documents and lying in a series of letters regarding alleged off-label use of a drug (Wellbutrin).

Previous page 1 Next page